{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T19:26:01Z","timestamp":1793474761816,"version":"4.5.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Therapeutic drug monitoring is standard practice for the immunosuppressant tacrolimus (Tac). Venous blood sampling at outpatient clinics is time-consuming and impractical with regard to obtaining trough concentrations on clinical visit days. Home-based blood sampling may be patient friendly and pave the way for limited sampling strategies for the prediction of total drug exposure. The aim was to establish a Tac assay for dried capillary microsamples, ensuring reliable measurements during the full dose interval in renal transplant recipients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>An assay based on volumetric absorptive microsampling and liquid chromatography tandem mass spectrometry was validated. The agreement between capillary microsamples and liquid venous samples was investigated in stable renal recipients on twice-daily Tac dosing. Sampling throughout the 12-hour dose interval was examined at 2 separate days, at least 1 week apart, for each participant. Two sets of samples were obtained at each time point, one delivered directly to the laboratory and one sent through mail.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Twenty-seven renal transplant recipients were included, of whom 26 were investigated twice. Tac was efficiently extracted from the dried microsamples (mean recovery 94%\u2013103%). The between-series mean accuracy was 88%\u201398% with coefficients of variation \u22645.0% (\u226411% at the lower limit of quantification), measurement range 0.70\u201360 mcg\/L. The mean difference between parallel microsamples was 5%\u20137%. Overall, the mean differences between dried microsamples and liquid samples were \u22123.1% when mailed (n = 679) and \u22124.2% when directly delivered (n = 682). Less than 8% were outside \u00b120%. The microsamples were stable for 1 month at ambient temperature.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The microsample method demonstrated acceptable performance. Tac concentrations can be reliably quantified throughout the dose interval by using volumetric absorptive microsampling in renal transplant recipients, and the results are not influenced by postal shipment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ftd.0000000000000655","type":"journal-article","created":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T11:13:45Z","timestamp":1558005225000},"page":"607-614","source":"Crossref","is-referenced-by-count":57,"title":["Tacrolimus Can Be Reliably Measured With Volumetric Absorptive Capillary Microsampling Throughout the Dose Interval in Renal Transplant Recipients"],"prefix":"10.1097","volume":"41","author":[{"given":"Nils T.","family":"Vethe","sequence":"first","affiliation":[{"name":"Pharmacology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marte T.","family":"Gustavsen","sequence":"additional","affiliation":[{"name":"Transplantation Medicine, Oslo University Hospital; and"},{"name":"School of Pharmacy, University of Oslo, Oslo, Norway."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Midtvedt","sequence":"additional","affiliation":[{"name":"Transplantation Medicine, Oslo University Hospital; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May E.","family":"Lauritsen","sequence":"additional","affiliation":[{"name":"Pharmacology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders M.","family":"Andersen","sequence":"additional","affiliation":[{"name":"Pharmacology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"\u00c5sberg","sequence":"additional","affiliation":[{"name":"Transplantation Medicine, Oslo University Hospital; and"},{"name":"School of Pharmacy, University of Oslo, Oslo, Norway."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stein","family":"Bergan","sequence":"additional","affiliation":[{"name":"Pharmacology and"},{"name":"School of Pharmacy, University of Oslo, Oslo, Norway."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230814","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med."},{"key":"R2-20230814","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1517\/14656566.2011.552428","article-title":"Current immunosuppressive treatment after kidney transplantation","volume":"12","author":"Kho","year":"2011","journal-title":"Expert Opin Pharmacother."},{"key":"R3-20230814","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/FTD.0b013e3181aa36cd","article-title":"New insights into the pharmacokinetics and pharmacodynamics of the calcineurin inhibitors and mycophenolic acid: possible consequences for therapeutic drug monitoring in solid organ transplantation","volume":"31","author":"de Jonge","year":"2009","journal-title":"Ther Drug Monit."},{"key":"R4-20230814","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/FTD.0b013e318198d092","article-title":"Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference","volume":"31","author":"Wallemacq","year":"2009","journal-title":"Ther Drug Monit."},{"key":"R5-20230814","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2165\/00003088-200443100-00001","article-title":"Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation","volume":"43","author":"Staatz","year":"2004","journal-title":"Clin Pharmacokinet."},{"key":"R6-20230814","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1472-8206.2007.00468.x","article-title":"Circadian and time-dependent variability in tacrolimus pharmacokinetics","volume":"21","author":"Park","year":"2007","journal-title":"Fundam Clin Pharmacol."},{"key":"R7-20230814","doi-asserted-by":"crossref","first-page":"e0167433","DOI":"10.1371\/journal.pone.0167433","article-title":"Cost evaluation of dried blood spot home sampling as compared to conventional sampling for therapeutic drug monitoring in children","volume":"11","author":"Martial","year":"2016","journal-title":"PLoS One."},{"key":"R8-20230814","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/FTD.0b013e318285e779","article-title":"Lessons from routine dose adjustment of tacrolimus in renal transplant patients based on global exposure","volume":"35","author":"Saint-Marcoux","year":"2013","journal-title":"Ther Drug Monit."},{"key":"R9-20230814","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1097\/TP.0000000000000708","article-title":"Improved tacrolimus target concentration achievement using computerized dosing in renal transplant recipients\u2014A prospective, randomized study","volume":"99","author":"St\u00f8rset","year":"2015","journal-title":"Transplantation."},{"key":"R10-20230814","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.phrs.2018.02.016","article-title":"Pharmacokinetic models to assist the prescriber in choosing the best tacrolimus dose","volume":"130","author":"Woillard","year":"2018","journal-title":"Pharmacol Res."},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/FTD.0000000000000422","article-title":"Dried blood spot sampling for tacrolimus and mycophenolic acid in children: analytical and clinical validation","volume":"39","author":"Martial","year":"2017","journal-title":"Ther Drug Monit."},{"key":"R12-20230814","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.4155\/bio.11.132","article-title":"EBF recommendation on the validation of bioanalytical methods for dried blood spots","volume":"3","author":"Timmerman","year":"2011","journal-title":"Bioanalysis."},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s40262-014-0177-7","article-title":"Therapeutic drug monitoring by dried blood spot: progress to date and future directions","volume":"53","author":"Wilhelm","year":"2014","journal-title":"Clin Pharmacokinet."},{"key":"R14-20230814","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00228-013-1584-7","article-title":"Importance of hematocrit for a tacrolimus target concentration strategy","volume":"70","author":"St\u00f8rset","year":"2014","journal-title":"Eur J Clin Pharmacol."},{"key":"R15-20230814","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.4155\/bio.15.111","article-title":"Hematocrit-independent recovery is a key for bioanalysis using volumetric absorptive microsampling devices, Mitra\u2122","volume":"7","author":"Mano","year":"2015","journal-title":"Bioanalysis."},{"key":"R16-20230814","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/FTD.0000000000000539","article-title":"Longitudinal study of tacrolimus in lymphocytes during the first year after kidney transplantation","volume":"40","author":"Klaasen","year":"2018","journal-title":"Ther Drug Monit."},{"key":"R18-20230814","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/nep.12738","article-title":"Low-target tacrolimus in de novo standard risk renal transplant recipients: a single-centre experience","volume":"21","author":"St\u00f8rset","year":"2016","journal-title":"Nephrology (Carlton)."},{"key":"R19-20230814","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jpba.2017.07.029","article-title":"Volumetric absorptive microsampling: current advances and applications","volume":"147","author":"Kok","year":"2018","journal-title":"J Pharm Biomed Anal."},{"key":"R20-20230814","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1111\/bcp.13755","article-title":"Therapeutic drug monitoring of tacrolimus and mycophenolic acid in outpatient renal transplant recipients using a volumetric dried blood spot sampling device","volume":"84","author":"Zwart","year":"2018","journal-title":"Br J Clin Pharmacol."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000655","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T22:22:10Z","timestamp":1692051730000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000655","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}